Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Anesth Analg ; 133(3): 610-619, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-33497061

RESUMEN

BACKGROUND: Residual neuromuscular blockade is associated with an increased incidence of postoperative respiratory complications. The REsidual neuromuscular block Prediction Score (REPS) identifies patients at high risk for residual neuromuscular blockade after surgery. METHODS: A total of 101,510 adults undergoing noncardiac surgery under general anesthesia from October 2005 to December 2018 at a tertiary care center in Massachusetts were analyzed for the primary outcome of postoperative respiratory complications (invasive mechanical ventilation requirement within 7 postoperative days or immediate postextubation desaturation [oxygen saturation {Spo2} <90%] within 10 minutes). The primary objective was to assess the association between the REPS and respiratory complications. The secondary objective was to compare REPS and train-of-four (TOF) ratio <0.90 on the strength of their association with respiratory complications. RESULTS: A high REPS (≥4) was associated with an increase in odds of respiratory complications (adjusted odds ratio [OR], 1.13 [95% confidence interval {CI}, 1.06-1.21]; P < .001). In 6224 cases with available TOF ratio measurements, a low TOF ratio (<0.9) was associated with respiratory complications (adjusted OR, 1.43 [95% CI, 1.11-1.85]; P = .006), whereas a high REPS was not (adjusted OR, 0.96 [95% CI, 0.74-1.23]; P = .73) (P = .018 for comparison between ORs). CONCLUSIONS: The REPS may be implemented as a screening tool to encourage clinicians to use quantitative neuromuscular monitoring in patients at risk of residual neuromuscular blockade. A positive REPS should be followed by a quantitative assessment of the TOF ratio.


Asunto(s)
Anestesia General , Reglas de Decisión Clínica , Retraso en el Despertar Posanestésico/etiología , Pulmón/inervación , Bloqueo Neuromuscular/efectos adversos , Monitoreo Neuromuscular , Trastornos Respiratorios/etiología , Respiración , Adulto , Anciano , Anestesia General/efectos adversos , Retraso en el Despertar Posanestésico/diagnóstico , Retraso en el Despertar Posanestésico/fisiopatología , Retraso en el Despertar Posanestésico/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Trastornos Respiratorios/diagnóstico , Trastornos Respiratorios/fisiopatología , Trastornos Respiratorios/terapia , Respiración Artificial , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo
2.
Anesth Analg ; 131(1): 141-151, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-31702700

RESUMEN

BACKGROUND: Pulmonary complications related to residual neuromuscular blockade lead to morbidity and mortality. Using an interrupted time series design, we tested whether proportions of reintubation for respiratory failure or new noninvasive ventilation were changed after a system-wide transition of the standard reversal agent from neostigmine to sugammadex. METHODS: Adult patients undergoing a procedure with general anesthesia that included pharmacologic reversal of neuromuscular blockade and admission ≥1 night were eligible. Groups were determined by date of surgery: August 15, 2015 to May 10, 2016 (presugammadex), and August 15, 2016 to May 11, 2017 (postsugammadex). The period from May 11, 2016 to August 14, 2016 marked the institutional transition (washout/wash-in) from neostigmine to sugammadex. The primary outcome was defined as a composite of reintubation for respiratory failure or new noninvasive ventilation. Event proportions were parsed into 10-day intervals in each cohort, and trend lines were fitted. Segmented logistic regression models appropriate for an interrupted time series design and adjusting for potential confounders were utilized to evaluate the immediate effect of the implementation of sugammadex and on the difference between preintervention and postintervention slopes of the outcomes. Models containing all parameters (full) and only significant parameters (parsimonious) were fitted and are reported. RESULTS: Of 13,031 screened patients, 7316 patients were included. The composite respiratory outcome occurred in 6.1% of the presugammadex group and 4.2% of the postsugammadex group. Adjusted odds ratio (OR) and 95% confidence intervals (CIs) for the composite respiratory outcome were 0.795 (95% CI, 0.523-1.208) for the immediate effect of intervention, 0.986 (95% CI, 0.959-1.013) for the difference between preintervention and postintervention slopes in the full model, and 0.667 (95% CI, 0.536-0.830) for the immediate effect of the intervention in the parsimonious model. CONCLUSIONS: The system-wide transition of the standard pharmacologic reversal agent from neostigmine to sugammadex was associated with a reduction in the odds of the composite respiratory outcome. This observation is supported by nonsignificant within-group time trends and a significant reduction in intercept/level from presugammadex to postsugammadex in a parsimonious logistic regression model adjusting for covariates.


Asunto(s)
Análisis de Series de Tiempo Interrumpido/métodos , Neostigmina/administración & dosificación , Bloqueo Neuromuscular/efectos adversos , Ventilación no Invasiva/métodos , Insuficiencia Respiratoria/tratamiento farmacológico , Sugammadex/administración & dosificación , Adulto , Anciano , Inhibidores de la Colinesterasa/administración & dosificación , Retraso en el Despertar Posanestésico/diagnóstico , Retraso en el Despertar Posanestésico/terapia , Femenino , Humanos , Intubación Intratraqueal/métodos , Masculino , Persona de Mediana Edad , Insuficiencia Respiratoria/diagnóstico
3.
Rev. esp. anestesiol. reanim ; 66(7): 394-404, ago.-sept. 2019. tab, graf
Artículo en Español | IBECS | ID: ibc-187554

RESUMEN

El shock hemorrágico es una de las principales causas de muerte en los pacientes politraumáticos graves. Para aumentar la supervivencia de estos pacientes se ha desarrollado una estrategia combinada de tratamiento conocida como Control de Daños. Los objetivos de este artículo son analizar el concepto actual de la Reanimación de Control de Daños y sus tres niveles de tratamiento, describir la mejor estrategia transfusional y abordar la coagulopatía aguda del paciente traumático como entidad propia. Se describen también los potenciales cambios que podrían producirse en los próximos años en esta estrategia de tratamiento


Haemorrhagic shock is one of the main causes of mortality in severe polytrauma patients. To increase the survival rates, a combined strategy of treatment known as Damage Control has been developed. The aims of this article are to analyse the actual concept of Damage Control Resuscitation and its three treatment levels, describe the best transfusion strategy, and approach the acute coagulopathy of the traumatic patient as an entity. The potential changes of this therapeutic strategy over the coming years are also described


Asunto(s)
Humanos , Traumatismo Múltiple/cirugía , Choque Hemorrágico/terapia , Retraso en el Despertar Posanestésico/terapia , Pérdida de Sangre Quirúrgica/prevención & control , Fluidoterapia/métodos , Traumatismo Múltiple/complicaciones , Sala de Recuperación/organización & administración , Ácido Tranexámico/uso terapéutico , Transfusión Sanguínea/métodos , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico
4.
Am J Case Rep ; 19: 10-12, 2018 01 03.
Artículo en Inglés | MEDLINE | ID: mdl-29295971

RESUMEN

BACKGROUND Ketamine is used as an induction and sedation agent in emergency departments and operating rooms throughout the country. Despite its widespread clinical use, there are few cases of significant morbidity and mortality attributed to ketamine overdose in the clinical setting. CASE REPORT The anesthesia provider in the room was an oral maxillofacial surgeon who inadvertently took out a more highly concentrated bottle of ketamine that is typically used for pediatric patients. The patient received 950 mg (100 mg/ml concentration) of intravenous ketamine instead of the intended 95 mg (10 mg/ml concentration). After the ketamine was given, there were no signs to any involved provider that a mistake had occurred until the wake-up appeared to be unusually prolonged. CONCLUSIONS Despite this, the patient did not demonstrate any systemic effects such as hemodynamic or CNS perturbations other than prolonged awakening. This case highlights one (drug overdose) of many causes of delayed emergence from anesthesia and reminds the provider caring for the patient to be mindful of drug concentrations used when preparing to sedate a patient, as relying on effects of the parent drug is not always adequate.


Asunto(s)
Anestesia General , Anestésicos Disociativos , Retraso en el Despertar Posanestésico/diagnóstico , Ketamina , Laringoscopía , Errores de Medicación , Pliegues Vocales/patología , Anciano , Anestesia General/métodos , Anestésicos Disociativos/efectos adversos , Retraso en el Despertar Posanestésico/terapia , Sobredosis de Droga , Humanos , Ketamina/efectos adversos , Laringoscopía/métodos , Masculino , Resultado del Tratamiento
6.
Anaesthesist ; 66(6): 422-425, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28265685

RESUMEN

Delayed recovery from anesthesia remains a very challenging subject for anesthesiologists. This case report describes the clinical course of delayed recovery from neuromuscular blockade after laparoscopic partial nephrectomy in a patient on simvastatin. The patient was hypertensive on regular treatment with oral captopril 25 mg twice daily and amlodipine 5 mg once daily and hypercholesterolemic on regular simvastatin 40 mg once daily with a normal electrocardiogram (ECG). All preoperative laboratory findings were within normal ranges. The patient was premedicated with midazolam 1 mg and general anesthesia was induced with fentanyl 2 µg/kg body weight, propofol 2 mg/kg and rocuronium bromide 0.6 mg/kg to facilitate tracheal intubation. Anesthesia was maintained with inhalation of isoflurane 1.0-1.5 % in 40 % oxygen-enriched air and 25 µg boluses of fentanyl. The patient did not require any additional rocuronium throughout surgery which was finished after 4 h. The patient most probably had preoperative simvastatin-induced myotoxicity. This potentiated the muscle relaxant effect of rocuronium bromide and was the reason for patient unresponsiveness and delayed postoperative recovery. We can conclude that anesthesiologists should preoperatively identify statin myotoxicity and to avoid neuromuscular blocking drugs for statin-treated patients. Also, preoperative adjustment of statin dosage may be recommended.


Asunto(s)
Retraso en el Despertar Posanestésico/terapia , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Laparoscopía/métodos , Nefrectomía/métodos , Bloqueo Neuromuscular/efectos adversos , Complicaciones Posoperatorias/inducido químicamente , Simvastatina/efectos adversos , Androstanoles/efectos adversos , Anestesia , Femenino , Humanos , Persona de Mediana Edad , Enfermedades Musculares/inducido químicamente , Enfermedades Musculares/terapia , Fármacos Neuromusculares no Despolarizantes/efectos adversos , Rocuronio
8.
Ann Fr Anesth Reanim ; 32(12): e189-91, 2013 Dec.
Artículo en Francés | MEDLINE | ID: mdl-24184167

RESUMEN

Regarding immediate post-anaesthesia problems, one must distinguish slow awakening and the apparition of neurologic or behavioural problems. Post-anaesthesia delirium, an usual cause of transient agitation in the recovery room following halogenated-based anaesthetic, is not included in this discussion. There are two false causes of slow awakening: residual curarization and a total spinal. Slow awakening is usually caused by overdose, either absolute or relative. Regarding the occurrence of neurologic or behavioural problems, one must consider situations at risk, patients at risk, the consequences of iatrogenicity but also the unknown cerebral tumour or metabolic disorder.


Asunto(s)
Periodo de Recuperación de la Anestesia , Anestesia/efectos adversos , Retraso en el Despertar Posanestésico/terapia , Anestésicos/administración & dosificación , Anestésicos/efectos adversos , Conducta/efectos de los fármacos , Niño , Sobredosis de Droga , Humanos , Enfermedades del Sistema Nervioso/inducido químicamente , Bloqueo Neuromuscular , Fármacos Neuromusculares no Despolarizantes , Agitación Psicomotora/etiología , Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA